Andrew Fein
Stock Analyst at HC Wainwright & Co.
(4.47)
# 294
Out of 5,090 analysts
586
Total ratings
51.03%
Success rate
21.57%
Average return
Main Sectors:
Stocks Rated by Andrew Fein
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AMLX Amylyx Pharmaceuticals | Maintains: Buy | $16 → $20 | $14.20 | +40.85% | 21 | Nov 7, 2025 | |
| ALEC Alector | Maintains: Buy | $10 → $5 | $1.22 | +309.84% | 11 | Oct 22, 2025 | |
| UTHR United Therapeutics | Maintains: Buy | $400 → $500 | $489.31 | +2.18% | 17 | Sep 5, 2025 | |
| BIIB Biogen | Maintains: Buy | $187 → $194 | $181.30 | +7.00% | 22 | Aug 1, 2025 | |
| FULC Fulcrum Therapeutics | Upgrades: Buy | $4 → $12 | $8.90 | +34.83% | 18 | Jul 29, 2025 | |
| KALV KalVista Pharmaceuticals | Reiterates: Buy | $27 | $16.43 | +64.33% | 16 | Jul 11, 2025 | |
| CADL Candel Therapeutics | Assumes: Buy | $23 | $5.33 | +331.52% | 1 | Jun 30, 2025 | |
| KYMR Kymera Therapeutics | Maintains: Buy | $54 → $60 | $66.62 | -9.94% | 8 | Jun 26, 2025 | |
| ACAD ACADIA Pharmaceuticals | Reiterates: Buy | $32 | $27.44 | +16.62% | 20 | Jun 26, 2025 | |
| VRTX Vertex Pharmaceuticals | Reiterates: Buy | $550 | $455.48 | +20.75% | 27 | Jun 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $90 → $120 | $204.00 | -41.18% | 15 | Jun 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $8 | $5.44 | +47.06% | 13 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $6 → $2 | $6.50 | -69.23% | 13 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $29 → $35 | $34.41 | +1.71% | 14 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $14 | $11.07 | +26.47% | 18 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $47 → $35 | $30.87 | +13.38% | 14 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $14 | $4.61 | +203.69% | 16 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $75 | $34.56 | +117.01% | 5 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $72 → $68 | $71.63 | -5.07% | 5 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $38 | $20.28 | +87.38% | 12 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $25 | $21.69 | +15.26% | 15 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $32 | $19.96 | +60.32% | 22 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $7.59 | +295.26% | 10 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $16 | $13.90 | +15.11% | 12 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $81 → $24 | $12.79 | +87.65% | 19 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $12 | $2.80 | +328.57% | 16 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $38 | $100.49 | -62.19% | 6 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $2.29 | +249.34% | 2 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $185 → $168 | $155.51 | +8.03% | 20 | Apr 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $11 | $1.86 | +491.40% | 11 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.39 | +619.42% | 18 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $22 | $7.49 | +193.72% | 12 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $120 → $20 | $8.66 | +130.95% | 16 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $12 | $2.09 | +474.16% | 12 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $4.36 | +198.17% | 14 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $7.08 | +55.37% | 10 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $5.58 | +312.19% | 14 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $1.08 | +1,288.89% | 13 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $85 | $96.14 | -11.59% | 16 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $35 | $23.53 | +48.75% | 14 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 | $10.24 | +632.42% | 7 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 | $43.30 | +73.21% | 1 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $7 | $2.67 | +162.17% | 6 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $4.08 | +145.10% | 5 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $150 | $0.79 | +18,887.34% | 1 | Jan 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $200 → $60 | $16.54 | +262.76% | 4 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $15 | $4.70 | +219.15% | 1 | Apr 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $40 | $1.06 | +3,673.58% | 3 | Mar 16, 2022 |
Amylyx Pharmaceuticals
Nov 7, 2025
Maintains: Buy
Price Target: $16 → $20
Current: $14.20
Upside: +40.85%
Alector
Oct 22, 2025
Maintains: Buy
Price Target: $10 → $5
Current: $1.22
Upside: +309.84%
United Therapeutics
Sep 5, 2025
Maintains: Buy
Price Target: $400 → $500
Current: $489.31
Upside: +2.18%
Biogen
Aug 1, 2025
Maintains: Buy
Price Target: $187 → $194
Current: $181.30
Upside: +7.00%
Fulcrum Therapeutics
Jul 29, 2025
Upgrades: Buy
Price Target: $4 → $12
Current: $8.90
Upside: +34.83%
KalVista Pharmaceuticals
Jul 11, 2025
Reiterates: Buy
Price Target: $27
Current: $16.43
Upside: +64.33%
Candel Therapeutics
Jun 30, 2025
Assumes: Buy
Price Target: $23
Current: $5.33
Upside: +331.52%
Kymera Therapeutics
Jun 26, 2025
Maintains: Buy
Price Target: $54 → $60
Current: $66.62
Upside: -9.94%
ACADIA Pharmaceuticals
Jun 26, 2025
Reiterates: Buy
Price Target: $32
Current: $27.44
Upside: +16.62%
Vertex Pharmaceuticals
Jun 23, 2025
Reiterates: Buy
Price Target: $550
Current: $455.48
Upside: +20.75%
Jun 11, 2025
Maintains: Buy
Price Target: $90 → $120
Current: $204.00
Upside: -41.18%
May 29, 2025
Maintains: Buy
Price Target: $14 → $8
Current: $5.44
Upside: +47.06%
May 29, 2025
Downgrades: Neutral
Price Target: $6 → $2
Current: $6.50
Upside: -69.23%
May 28, 2025
Maintains: Buy
Price Target: $29 → $35
Current: $34.41
Upside: +1.71%
May 27, 2025
Maintains: Buy
Price Target: $30 → $14
Current: $11.07
Upside: +26.47%
May 14, 2025
Maintains: Buy
Price Target: $47 → $35
Current: $30.87
Upside: +13.38%
May 14, 2025
Maintains: Buy
Price Target: $20 → $14
Current: $4.61
Upside: +203.69%
May 12, 2025
Maintains: Buy
Price Target: $80 → $75
Current: $34.56
Upside: +117.01%
May 12, 2025
Maintains: Buy
Price Target: $72 → $68
Current: $71.63
Upside: -5.07%
May 9, 2025
Maintains: Buy
Price Target: $46 → $38
Current: $20.28
Upside: +87.38%
May 8, 2025
Maintains: Buy
Price Target: $40 → $25
Current: $21.69
Upside: +15.26%
May 7, 2025
Maintains: Buy
Price Target: $80 → $32
Current: $19.96
Upside: +60.32%
May 6, 2025
Reiterates: Buy
Price Target: $30
Current: $7.59
Upside: +295.26%
May 5, 2025
Maintains: Buy
Price Target: $7 → $16
Current: $13.90
Upside: +15.11%
May 2, 2025
Maintains: Buy
Price Target: $81 → $24
Current: $12.79
Upside: +87.65%
May 1, 2025
Maintains: Buy
Price Target: $16 → $12
Current: $2.80
Upside: +328.57%
Apr 30, 2025
Reiterates: Buy
Price Target: $38
Current: $100.49
Upside: -62.19%
Apr 28, 2025
Reiterates: Buy
Price Target: $8
Current: $2.29
Upside: +249.34%
Apr 22, 2025
Maintains: Buy
Price Target: $185 → $168
Current: $155.51
Upside: +8.03%
Mar 28, 2025
Maintains: Buy
Price Target: $15 → $11
Current: $1.86
Upside: +491.40%
Mar 27, 2025
Reiterates: Buy
Price Target: $10
Current: $1.39
Upside: +619.42%
Mar 26, 2025
Reiterates: Buy
Price Target: $22
Current: $7.49
Upside: +193.72%
Mar 17, 2025
Downgrades: Neutral
Price Target: $120 → $20
Current: $8.66
Upside: +130.95%
Mar 14, 2025
Maintains: Buy
Price Target: $10 → $12
Current: $2.09
Upside: +474.16%
Mar 7, 2025
Reiterates: Buy
Price Target: $13
Current: $4.36
Upside: +198.17%
Mar 6, 2025
Reiterates: Buy
Price Target: $11
Current: $7.08
Upside: +55.37%
Mar 6, 2025
Reiterates: Buy
Price Target: $23
Current: $5.58
Upside: +312.19%
Mar 6, 2025
Reiterates: Buy
Price Target: $15
Current: $1.08
Upside: +1,288.89%
Mar 3, 2025
Reiterates: Buy
Price Target: $85
Current: $96.14
Upside: -11.59%
Feb 28, 2025
Reiterates: Buy
Price Target: $35
Current: $23.53
Upside: +48.75%
Feb 18, 2025
Reiterates: Buy
Price Target: $75
Current: $10.24
Upside: +632.42%
Jan 13, 2025
Reiterates: Buy
Price Target: $75
Current: $43.30
Upside: +73.21%
Nov 2, 2023
Maintains: Buy
Price Target: $17 → $7
Current: $2.67
Upside: +162.17%
Aug 15, 2023
Reiterates: Buy
Price Target: $10
Current: $4.08
Upside: +145.10%
Jan 31, 2023
Reiterates: Buy
Price Target: $150
Current: $0.79
Upside: +18,887.34%
May 5, 2022
Downgrades: Neutral
Price Target: $200 → $60
Current: $16.54
Upside: +262.76%
Apr 27, 2022
Assumes: Buy
Price Target: $15
Current: $4.70
Upside: +219.15%
Mar 16, 2022
Maintains: Neutral
Price Target: $80 → $40
Current: $1.06
Upside: +3,673.58%